Cramer Rosenthal McGlynn’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-99,113
| Closed | -$9.98M | – | 139 |
|
2018
Q4 | $9.98M | Sell |
99,113
-262,447
| -73% | -$26.4M | 0.25% | 105 |
|
2018
Q3 | $46.2M | Sell |
361,560
-206,310
| -36% | -$26.3M | 0.88% | 50 |
|
2018
Q2 | $61.4M | Buy |
567,870
+5,931
| +1% | +$642K | 1.1% | 34 |
|
2018
Q1 | $59.5M | Buy |
561,939
+78,957
| +16% | +$8.36M | 0.97% | 41 |
|
2017
Q4 | $56.6M | Sell |
482,982
-219,531
| -31% | -$25.7M | 0.91% | 43 |
|
2017
Q3 | $79.9M | Buy |
702,513
+442,525
| +170% | +$50.3M | 1.28% | 20 |
|
2017
Q2 | $32.4M | Sell |
259,988
-77,470
| -23% | -$9.66M | 0.5% | 86 |
|
2017
Q1 | $40M | Buy |
337,458
+26,744
| +9% | +$3.17M | 0.61% | 73 |
|
2016
Q4 | $31.1M | Buy |
310,714
+196,380
| +172% | +$19.7M | 0.46% | 90 |
|
2016
Q3 | $14.4M | Buy |
114,334
+1,542
| +1% | +$195K | 0.22% | 143 |
|
2016
Q2 | $13.2M | Sell |
112,792
-54,593
| -33% | -$6.38M | 0.21% | 144 |
|
2016
Q1 | $17.3M | Buy |
167,385
+22,778
| +16% | +$2.36M | 0.27% | 119 |
|
2015
Q4 | $14.4M | Buy |
144,607
+84,826
| +142% | +$8.45M | 0.22% | 132 |
|
2015
Q3 | $5.45M | Buy |
+59,781
| New | +$5.45M | 0.07% | 178 |
|